Linezolid is NOT contraindicated in myasthenia gravis
Linezolid can be safely used in patients with myasthenia gravis, as it is not listed as a contraindication in the FDA drug label and has been successfully used in multiple published cases of MG patients. 1
FDA-Approved Contraindications
The FDA label for linezolid specifies clear contraindications, and myasthenia gravis is notably absent from this list 1. The actual contraindications are:
- Known hypersensitivity to linezolid
- Concurrent use of MAO inhibitors (or within 2 weeks of discontinuation)
- Uncontrolled hypertension, pheochromocytoma, or thyrotoxicosis (unless blood pressure monitored)
- Concurrent use of sympathomimetics, vasopressors, or dopaminergic agents (unless monitored)
- Concurrent use of serotonergic medications including SSRIs, tricyclics, triptans, meperidine, or buspirone (unless carefully observed for serotonin syndrome)
Real-World Evidence in MG Patients
Multiple case reports demonstrate successful linezolid use specifically in myasthenia gravis patients:
A 57-year-old man with steroid-dependent myasthenia gravis was successfully treated with linezolid for disseminated Mycobacterium chelonae infection 2
A patient with myasthenia gravis and disseminated Nocardia farcinica infection was successfully treated with linezolid, showing good long-term tolerance 3
A 41-year-old woman with myasthenia gravis and E. faecium bacteremia was successfully desensitized to linezolid after an initial hypersensitivity reaction, demonstrating that even allergic reactions can be managed in MG patients when linezolid is necessary 4
Clinical Guideline Support
The IDSA guidelines for MRSA infections list linezolid as an appropriate alternative for multiple serious infections including CNS infections, pneumonia, bone/joint infections, and complicated skin infections 5. These recommendations apply to the general population without specific exclusions for myasthenia gravis.
Important Caveats
While linezolid is not contraindicated in MG, be aware of:
- Peripheral neuropathy and optic neuropathy can occur with prolonged use (>28 days), which could theoretically complicate MG symptom assessment
- Myelosuppression requires monitoring with weekly CBC, especially important in MG patients on multiple immunosuppressive agents
- The drug-drug interactions listed above remain critical regardless of MG status
Use linezolid when clinically indicated in MG patients, following standard dosing (600 mg PO/IV twice daily for adults) and monitoring protocols, without concern for MG-specific contraindications.